Patents by Inventor Timothy J. Collier

Timothy J. Collier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Erythropoietin administration to improve graft survival
    Patent number: 7459152
    Abstract: The present invention provides methods, compounds and kits for increasing the viability of cells. The methods involve treating cells that make up a tissue graft with erythropoietin before, during or after delivery or administration. The method can employ cells of different types, including cells of neural or paraneural origin, such as adrenal chromaffin cells. Also useful are cell lines grown in vitro. Cells not of neural or paraneural origin, such as fibroblasts, may also be used following genetic alteration to express a desired neural product such as a neurotransmitter or a neuronal growth factor. The method is used to treat neurological diseases such as Parkinson's disease, Alzheimer's disease, Huntington's disease, epilepsy, and traumatic brain or spinal cord injury.
    Type: Grant
    Filed: April 23, 2004
    Date of Patent: December 2, 2008
    Assignee: Rush University Medical Center
    Inventors: Caryl E. Sortwell, Timothy J. Collier
  • Erythropoietin administration to improve graft survival
    Publication number: 20040259071
    Abstract: The present invention provides methods, compounds and kits for increasing the viability of cells. The methods involve treating cells that make up a tissue graft with erythropoietin before, during or after delivery or administration. The method can employ cells of different types, including cells of neural or paraneural origin, such as adrenal chromaffin cells. Also useful are cell lines grown in vitro. Cells not of neural or paraneural origin, such as fibroblasts, may also be used following genetic alteration to express a desired neural product such as a neurotransmitter or a neuronal growth factor. The method is used to treat neurological diseases such as Parkinson's disease, Alzheimer's disease, Huntington's disease, epilepsy, and traumatic brain or spinal cord injury.
    Type: Application
    Filed: April 23, 2004
    Publication date: December 23, 2004
    Applicant: Rush University Medical Center
    Inventors: Caryl E. Sortwell, Timothy J. Collier
  • Dopaminergic neurotrophic factor for treatment of Parkinson's disease
    Patent number: 5215969
    Abstract: Dopaminergic Neurotrophic Factor (DNTF), derived from cells of the peripheral nervous system, is administered to patients suffering from Parkinson's Disease in an amount effective to facilitate survival of substantia nigra dopamine nerve cells.
    Type: Grant
    Filed: December 9, 1991
    Date of Patent: June 1, 1993
    Assignees: Hahnemann University, University of Rochester
    Inventors: Joe E. Springer, Timothy J. Collier